A peptide Certificate of Analysis is most useful when it can answer a defined set of questions about a specific material. It should identify what was tested, connect the sample to a batch, name the analytical procedures, and report the resulting data. It should not be treated as a general certificate of safety or suitability.
A disciplined review therefore begins with traceability, not with the largest percentage on the page. The following sequence helps a laboratory determine what a COA supports, what remains untested, and whether the document belongs to the material under review.
1. Confirm the Document and Issuing Laboratory
Start with the report itself. Look for the laboratory name, report or sample identifier, issue or completion date, and an authorized signature or comparable approval control. If a QR code or verification link is provided, it should resolve to a source controlled by the issuing laboratory rather than an editable copy supplied by a seller.
Claims of accreditation deserve a second check. Confirm the laboratory in the accrediting body's directory and review the relevant scope, because accreditation of one activity does not automatically cover every method or analyte. A professional layout is useful for navigation, but appearance alone does not establish authenticity.
Also check whether the document has a revision number or replacement status. When a laboratory reissues a report to correct a field, retain the current authorized version and retire earlier copies from the active material record. Two versions circulating under the same report number can create an avoidable traceability conflict.
2. Connect the COA to One Material Batch
The compound name is only the first identifier. A useful report also carries a batch or lot number that can be matched to the vial, package, inventory record, or supplier documentation. Sample IDs and internal laboratory IDs serve different purposes: they track the submitted specimen and the laboratory's workflow, but they do not necessarily identify the supplier's production lot.
If the batch field is missing, unclear, or different from the material received, stop the review and request clarification. Do not infer a match from the product name or test date. Without a traceable connection, valid analytical results may still belong to another sample.
3. Separate Identity, Purity, and Content
These terms describe different analytical questions. Identity asks whether the target compound is present. Purity estimates the proportion of the principal component relative to detectable related material under a stated method. Content or assay estimates how much target material is present, often expressed per vial, unit, mass, or volume.
A high chromatographic area percentage does not prove that a vial contains its labeled amount. It also does not automatically address water, counterions, residual solvents, microbial burden, or endotoxin. Each conclusion requires a method capable of measuring that attribute.
4. Read Methods, Results, and Limits Together
| COA element | Question to ask |
|---|---|
| Test or attribute | Was identity, purity, content, or another property evaluated? |
| Method reference | Is the procedure named or linked to a controlled method? |
| Numerical result | Are units and calculation basis clear? |
| Acceptance limit | Was a specification stated, and did the result meet it? |
HPLC may support purity or assay work when the procedure is suitable, but the instrument name alone is not enough. Review wavelength or detector context, reference standard use, integration approach, and specificity when those details are available. Mass spectrometry can support molecular identity, yet a matching mass does not quantify every impurity. Methods must be interpreted according to their intended purpose.
Supporting files can matter when a protocol requires deeper review. Chromatograms, spectra, calculations, and system-suitability records help show how a summary value was produced. Their presence does not make a weak method strong, but they allow qualified reviewers to examine assignments, integrations, and unexpected responses instead of relying on the final number alone.
5. Treat Missing Information as Unreported
A blank field or absent test should be described as not reported, not as passed or failed. If a COA lists purity but no identity method, it supports only the result actually shown. Likewise, a report that does not mention sterility, endotoxin, residual moisture, or residual solvents provides no conclusion about those attributes.
Dates also need context. Received, tested, completed, and released may represent different events. There is no universal rule that every COA becomes invalid after a fixed number of months. Relevance depends on material stability, storage history, the laboratory's procedures, and the research protocol's own acceptance criteria.
6. Finish With a Fit-for-Purpose Review
Before accepting a COA, document five decisions: the report is authentic, the batch matches, the compound designation is clear, the methods address the required attributes, and the numerical results meet predefined protocol needs. Record any unresolved question rather than filling the gap with an assumption.
Regulatory quality guidance offers useful models for complete analytical reporting, but it does not convert a research-use-only material into an approved or clinically suitable product. A COA is one part of a laboratory evidence trail. Its value comes from specific, traceable data reviewed alongside internal procedures, material history, and the demands of the intended research method.
